Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 93,788

Document Document Title
WO/2016/150392A1
Provided are a transformant used for losing weight and reducing fat, and a construction method for the transformant. The transformant is a recombinant lactococcus lactis obtained by replacing a lactococcus lactis thymidylate synthase gen...  
WO/2016/149821A1
A method of preparing a morphinan alkaloid (MA) metabolite comprising: (a) culturing a host cell under conditions suitable for MA production including a first fermentation at a pH of between about 7.5 and about 10, said host cell compris...  
WO/2016/154297A1
The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The p...  
WO/2016/151257A1
The present invention relates to the use of a yeast extract including at least 10 wt % of nucleic acids, preferably at least 15 wt %, and more preferably 30 to 95 wt %, relative to the total weight of said extract, said nucleic acids bei...  
WO/2016/152697A1
The purpose of the present invention is to stably culture a gas-assimilating microorganism, regardless of fluctuations in the supply flow-rate of a substrate gas. In a reaction tank 10, a gas-assimilating microorganism b is cultured in a...  
WO/2016/151656A1
With this aromatic chlorine compound degradation agent characterized by containing Marasmiellus palmivorus and this method for degrading aromatic chlorine compounds by using the aromatic chlorine compound degradation agent, aromatic chlo...  
WO/2016/151545A1
Provided is a method of culturing one or more microorganisms. The method includes culturing one or more microorganisms in a medium comprising crude glycerol at a first concentration level, feeding to the media an additional amount of cru...  
WO/2016/152946A1
Provided is an affinity chromatography carrier in which high immunoglobulin-binding capacity and alkali resistance are maintained. Provided is an immunoglobulin-binding protein, wherein: the immunoglobulin-binding protein contains at lea...  
WO/2016/154314A1
The present invention relates to compositions and methods of producing carotenoids and carotenoid derivatives.  
WO/2016/152828A1
A tien-cha extract essence characterized in being obtained by subjecting a tien-cha extract to an activated carbon treatment, and a method for manufacturing a fermented food item using the tien-cha extract essence provide a technique tha...  
WO/2016/150357A1
Provided are an ophiobolin compound mother nucleus synthetic gene AuOS and application therefor. The gene is derived from Aspergillus ustus 094102, and a gene sequence, a cDNA sequence and an amino acid sequence of an encoding AuOS prote...  
WO/2016/149074A1
The invention provides a novel method for controlling and/or treating the growth of biofilms by promoting growth of the periphery cells and/or increasing nutrient consumption by the periphery cells so that the growth of peripheral cells ...  
WO/2016/148168A1
Provided is a more accurate method of evaluating the capacity of probiotics to be phagocytosed at the cellular level, which is also a method of uniformly evaluating the capacity of probiotics to be phagocytosed, which can easily be perfo...  
WO/2016/147046A1
Provided are novel microalgae that grow rapidly, demonstrate resistance to contamination by other microalgae, have a high lipid content, and have at least a lipid composition that is suitable for the production of biofuel, and a method f...  
WO/2016/149631A3
Provided herein, in some aspects, are methods and compositions for producing large- scale quantities of butanol, including normal butanol (n-butanol), isobutanol, and 2-butanol using a cell-free system.  
WO/2016/147162A1
The present invention relates to PCSK9 inhibitors and methods of use thereof. Specifically, the invention relates to PCSK9 cell-based assay, PCSK9 inhibiting polypeptides and derivatives thereof. The invention includes pharmaceutical com...  
WO/2016/149631A2
Provided herein, in some aspects, are methods and compositions for producing large- scale quantities of butanol, including normal butanol (n-butanol), isobutanol, and 2-butanol using a cell-free system.  
WO/2016/148044A1
The present invention provides modified aminoacyl-tRNA synthetase (ARS) which has improved reactivity with an N-methyl-amino acid compared with naturally occurring aminoacyl-tRNA synthetase. The modified aminoacyl-tRNA synthetase accordi...  
WO/2016/145974A1
Provided is a use of an attenuated gene engineering Salmonella typhimurium strain VPN 20009-M in the preparation of medicaments for preventing and treating cancer metastasis.  
WO/2016/149002A1
In one embodiment, the process combines a fraction (up to 15%) of a lignocellulose substrate with supplemental nutritional material and hydrates the fraction to a moisture content of from 40% to 70% by weight. The hydrated substrate frac...  
WO/2016/143210A1
The organic waste water processing apparatus according to an embodiment comprises an anaerobic processing reactor, a microbe deposit amount-determining mechanism, a flow-controlling mechanism, and a microbe amount-controlling mechanism. ...  
WO/2016/141446A1
The present invention relates to a solid culture medium composition containing specific colouring agents which allow yeasts (starters) inoculated during wine fermentation processes to be identified on the basis of the difference between ...  
WO/2016/143887A1
Provided is an antiallergic agent that can be produced without using heat energy or with relatively reduced usage of heat energy, can relatively reduce the burden of a user upon administration, and is easy to carry when, for example, goi...  
WO/2016/143873A1
[Problem] To provide an improved β-fructofuranosidase which is capable of efficiently producing kestose while inhibiting the production of nystose. [Solution] This improved β-fructofuranosidase comprises either: an amino acid sequence ...  
WO/2016/145378A1
Recombinant microorganisms engineered for the production of polyunsaturated fatty acids (PUFAs) are provided. Also provided are biomass, microbial oils, and food products and ingredients produced by or comprising the microorganisms of th...  
WO/2016/145176A3
Described in this application is a method for producing Plasmodium sporozoites in a cell-free, mosquito-free in vitro culture -system. Compositions and methods resulting from applying the methods of the present invention are described.  
WO/2016/142626A1
The present invention relates to a novel culture medium for mycobacteria, in particular mycobacteria of the Mycobacterium tuberculosis complex, which makes it possible to significantly reduce the delays in isolation by culturing and ther...  
WO/2016/145378A8
Recombinant microorganisms engineered for the production of polyunsaturated fatty acids (PUFAs) are provided. Also provided are biomass, microbial oils, and food products and ingredients produced by or comprising the microorganisms of th...  
WO/2016/143669A1
There is found a means for adhering cells or cell masses to each other with a protein such as an extracellular matrix protein to produce aggregated and immobilized cells. The purpose of the present invention is to apply the means for var...  
WO/2016/141454A1
The present invention relates to bacterial compositions and methods of use thereof. The bacterial compositions may include two or more bacteria of the genera Faecalibacterium, Lachnospira, Veillonella or Rothia. The bacterial composition...  
WO/2016/142503A1
The invention relates to microbial production of terpenes. Known processes of microbial production of terpenes are based mostly on direct conversion of sugars. It was therefore desirable to have alternative substrates, and especially alt...  
WO/2016/145101A1
A synthetic nucleic acid which encodes a protein wherein at least one optimal or non-optimal codon in a wild type nucleic acid encoding the protein has been replaced respectively with one or more non-optimal codons or optimal codons enco...  
WO/2016/145176A2
Described in this application is a method for producing Plasmodium sporozoites in a cell-free, mosquito-free in vitro culture -system. Compositions and methods resulting from applying the methods of the present invention are described.  
WO/2016/145432A1
Methods for improved cultivation media and culture conditions for Truepereiia pyogenes are disclosed herein. Also disclosed are improved methods for the isolation and purification of pyolysin from Truepereiia pyogenes.  
WO/2016/143702A1
The present invention provides an antibody which has an activity of binding specifically to human membrane-type ADAM28 at an epitope present in a domain lying between amino acid residue 524 and amino acid residue 659 in the amino acid se...  
WO/2016/142419A1
It is provided a process for the isolation of a strain of a bacterium Lactococcus lactis lactis with increased 2,3- butanediol production capacity, the process comprising subjecting strain CML B4 to two consecutive rounds of mutagenesis....  
WO/2016/140233A1
 The present invention provides a method for the industrial manufacture of chiral-1,1-difluoro-2-propanol. In particular, a chiral-1,1-difluoro-2-propanol can be manufactured with high optical purity and good yield by causing a micro-o...  
WO/2016/141121A1
This disclosure provides compositions, including Listeria delivery vectors comprising minigene expression constructs, and methods of using the same for inducing an immune response against an antigen-expressing tumor and for treating the ...  
WO/2016/140349A1
The purpose of the present invention is to provide a yeast that has been genetically modified for greater mass production of glutathione, and a method for producing glutathione using the yeast. Provided is a method for producing glutathi...  
WO/2016/140374A1
The purpose of the present invention is to provide a novel technology for producing biofuel, and, specifically, the present invention relates to a biofuel manufacturing method that includes coculturing of mixed microorganisms including p...  
WO/2016/138641A1
A candida parapsilosis CGMCC 9630. The bacterial strain expresses a carbonyl reductase and a coding gene and amino acid sequence of the carbonyl reductase, comprises a recombinant expression vector and a recombinant expression conversion...  
WO/2016/140966A1
A process of enhanced bio-alcohol production from molasses is provided herein. The process comprises contacting molasses with sodium benzoate, potassium sorbate or a mixture thereof followed by yeast fermentation resulting in at least 6 ...  
WO/2016/138869A1
Methods for production of polyunsaturated fatty acids (PUFAs) from coccolithophorid Pleurochrysis carterae are disclosed. This invention provides methods for producing eicosapentaenoic acid (EPA, 20: 5 n-3), docosahexaenoic acid (DHA, 22...  
WO/2016/139259A1
The invention relates to the use of a nutritional supplement, in an untreated or extracted form, obtained from fermentation with a mould or a bacterium, for the production of lactic acid by fermentation.  
WO/2016/138610A1
Provided is an albumin conjugated tumor necrosis factor related apoptosis-inducing ligand variant, and the variant is a fusion protein of tumor necrosis factor related apoptosis-inducing ligand and albumin binding domain. Also provided a...  
WO/2016/139217A1
A method for preparing a composition comprising anaerobic human intestinal microbiota, wherein the method comprises the step of anaerobic cultivation of a fecal sample from a healthy donor in a cultivation medium, wherein the cultivation...  
WO/2016/135700A1
Disclosed herein are microbial consortia and compositions including microbes for use in agricultural or biodegradation applications. In some embodiments, soil, plants, and/or plant parts (such as seeds, seedlings, shoots, roots, leaves, ...  
WO/2016/136942A1
The present invention relates to a colitis inhibitor which is safe and exhibits an excellent colitis inhibition effect, and a method for producing same. More specifically, the present invention relates to a colitis inhibitor that contain...  
WO/2016/135699A1
Disclosed herein are microbial consortia and compositions including microbes, for example, for use in agricultural or biodegradation applications. In some embodiments, soil, plants, and/or plant parts (such as seeds, seedlings, shoots, r...  
WO/2016/136620A1
The invention provides a method for synthesizing NAD+ or NADH in an enzyme reaction system that requires NAD+ or NADH to supplement the NAD+ lost due to thermal decomposition in the enzyme reaction system, and a transformant set for coen...  

Matches 151 - 200 out of 93,788